Not applicableStudy completedNCT01236053What this trial is testingCancer in Patients With Gabapentin (GPRD)Who this might be right forPain, NeuropathicEpilepsyRenal Pelvis Cancer+13 more GlaxoSmithKline 2,323,608
Testing effectiveness (Phase 2)Study completedNCT01631552What this trial is testingStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerWho this might be right forGastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more Gilead Sciences 515
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Early research (Phase 1)Study completedNCT03319459What this trial is testingFATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsWho this might be right forHER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more Fate Therapeutics 44
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Early research (Phase 1)Ended earlyNCT00689065What this trial is testingSafety Study of CALAA-01 to Treat Solid Tumor CancersWho this might be right forCancerSolid Tumor Calando Pharmaceuticals 24
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07410676What this trial is testingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsWho this might be right forCancerSarcomaLeukaemia+12 more Essen Biotech 83
Not applicableLooking for participantsNCT07059884What this trial is testingDistance-Based Exercise to Preserve Function and Prevent DisabilityWho this might be right forLocalized Malignant Solid NeoplasmAnal CancerBladder (Urothelial, Transitional Cell) Cancer+16 more Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Ended earlyNCT04504916What this trial is testingZilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)Who this might be right forTriple-negative Breast CancerNon-squamous Non-small-cell Lung CancerNSCLC+12 more VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 102
Early research (Phase 1)Looking for participantsNCT06465069What this trial is testingLY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 420
Early research (Phase 1)WithdrawnNCT01741597What this trial is testingDynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT03552718What this trial is testingQUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.Who this might be right forColorectal CancerBreast CancerHead and Neck Squamous Cell Carcinoma+4 more NantBioScience, Inc. 5
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)Looking for participantsNCT07145255What this trial is testingPhase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsWho this might be right forProstate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more MBrace Therapeutics 150
Early research (Phase 1)UnknownNCT02349724What this trial is testingA Clinical Research of CAR T Cells Targeting CEA Positive CancerWho this might be right forLung CancerColorectal CancerGastric Cancer+2 more Southwest Hospital, China 75
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Not applicableStudy completedNCT02340715What this trial is testingAdvanced MRI Sequences for Radiation Therapy Treatment PlanningWho this might be right forCancer Medical College of Wisconsin 158
Early research (Phase 1)UnknownNCT06256055What this trial is testingPhase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forMalignant MesotheliomaColorectal CancerBile Duct Cancer+4 more UTC Therapeutics Inc. 24
Not applicableStudy completedNCT04971304What this trial is testingComparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsWho this might be right forCancer, BreastCancer, LungCancer of Colon+3 more Catherine M. Lockhart 16,506